The prognostic value of CDKN2A/CDKN2B hemizygous deletion in meningioma remains uncertain

Neuro-Oncology · Published 2026-07-25 · DOI 10.1093/neuonc/noag158

Authors (5)

Junpeng Ma, Wei Chen, Yaqiang Hong, Dake Zhang, Liang Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ma, J., Chen, W., Hong, Y., et al. (2026). The prognostic value of CDKN2A/CDKN2B hemizygous deletion in meningioma remains uncertain. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag158

Related articles

• Comprehensive performance testing and external validation of an AI algorithm to detect and segment brain metastases · Neuro-Oncology · 2026 · Same journal
• Programmable microfluidic modeling of the glioblastoma immune microenvironment recapitulates temporally regulated tumor-immune signaling · Neuro-Oncology · 2026 · Same journal
• The European Association for Neuro-oncology consensus statement on radiation necrosis · Neuro-Oncology · 2026 · Same journal
• Point/Counterpoint: Dordaviprone for diffuse midline glioma - A landmark approval or a premature step? · Neuro-Oncology · 2026 · Same journal
• Genomic hallmarks of depot medroxyprogesterone acetate-associated meningiomas · Neuro-Oncology · 2026 · Same journal
• Society news · Neuro-Oncology · 2026 · Same journal
• MAPK-driven glioma progression and reprogramming of the tumor-associated immune response · Neuro-Oncology · 2026 · Same journal
• Professional Grief, Burnout and Coping among Neuro-Oncologists: A Cross-Sectional Online Study (PROGRESS) · Neuro-Oncology · 2026 · Same journal
• Carboplatin induces optic nerve oligodendrocyte loss and impairs myelin sheath microstructure in a mouse model of neurofibromatosis type 1 (NF1) · Neuro-Oncology · 2026 · Same journal
• The emerging roles of cerebral pericytes in brain metastasis · Neuro-Oncology · 2026 · Same journal